Monopar Therapeutics Inc. (MNPR) NASDAQ
61.26
-3.14(-4.88%)
Currency In USD
- General
- Statistics
- Historical Data
- Profile
- Financials
61.26
-3.14(-4.88%)
Currency In USD
| Market Cap | 483.94M |
| Enterprise Value | 422.26M |
| P/E Ratio | -34.89 |
| PEG Ratio | 1.24 |
| Price/Sales Ratio | 0 |
| Price/Book Ratio | 3.86 |
| Enterprise/Revenue | 0 |
| Enterprise/EBITDA | -19.97 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | March 31, 2026 |
| Profit Margin | 0 |
| Operating Margin | 0 |
| Return On Assets | -0.11 |
| Return On Equity | -0.13 |
| Revenue | 0 |
| Revenue/Share | 0 |
| Gross Profit | 0 |
| EBITDA | -16.7M |
| Net Income | -13.72M |
| Diluted EPS | -1.85 |
| Total Cash | 137.49M |
| Total Cash/Share | 16.11 |
| Total Debt | 131,565 |
| Total Debt/Equity | 0 |
| Current Ratio | 56.04 |
| Book Value Per Share | 15.86 |
| 52-Week Change | 104.13 |
| 52-Week High | 105 |
| 52-Week Low | 29.18 |
| Moving Average 50 Days | 57.61 |
| Moving Average 200 Days | 64.8 |
| Average Volume | 182,306 |
| Shares Outstanding | 6.7M |
| % Held by Institutions | 93.17 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | 1:5 |
| Last Split Date | August 13, 2024 |